Business
Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupply
Healogics Wound Care Supply adds UltraMIST to its Group Purchasing Organization Healogics iSupply and Sanuwave collaborate to provide UltraMIST as an option
About this update from Sanuwave Health, Inc.
[{"type":"text","content":"Healogics Wound Care Supply adds UltraMIST to its Group Purchasing Organization Healogics iSupply and Sanuwave collaborate to provide UltraMIST as an option for GPO members EDEN PRAIRIE, Minn., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the \"Company\" or \"Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce the addition of its UltraMIST product line to Healogics iSupply. With this expansion, UltraMIST becomes an option for iSupply members, including Wound Care Centers®, home health agencies, and skilled nursing facilities. Sanuwave plans to roll out the UltraMIST system to Healogics iSupply members at initial locations by the end of 2025. “We’re excited to collaborate with Healogics, the nation’s leader in wound care treatment and research,” said Morgan Frank, Sanuwave CEO. “Their network is one of the preeminent organizations in advanced wound care, and the opportunity to offer the UltraMIST product to its members and to collaborate with such a well-respected group is a fantastic opportunity for us, and we look forward to working with them.” Richard Galentino, President of Healogics Wound Care Supply added, “We continue to look for opportunities to partner with innovative organizations focused on wound healing technologies. We are excited that Sanuwave will be joining our GPO and providing our members with a cost-saving solution that is best-in-class from a patient care perspective.” About SanuwaveSanuwave Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. Sanuwave's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. Sanuwave applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions. About HealogicsFor nearly 30 years, Healogics has led the nation in advanced wound care, transforming lives through evidence-based treatment and innovation. Guided by its mission to FIND. TREAT. HEAL.™, Healogics partners with hospitals and health systems across the country to deliver specialize...